Stoke Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
19 Sep 24 | Sell€24,439,799 | Skorpios Trust | Company | 1,937,500 | €12.61 | |
17 Apr 24 | Sell€39,250,224 | Skorpios Trust | Company | 3,600,000 | €10.90 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 2,382,578 | 3.9% |
Hedge Funds | 13,734,237 | 22.5% |
Institutions | 45,042,364 | 73.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,906,181 | €97.0m | -17.9% | 99.84% | |||
5,570,150 | €60.7m | 2.98% | no data | |||
5,187,191 | €56.5m | 0.04% | 22.7% | |||
4,713,509 | €51.3m | -0.16% | 2.9% | |||
4,652,285 | €50.7m | 10.1% | 0.71% | |||
4,368,443 | €47.6m | 0% | 0.46% | |||
4,197,124 | €45.7m | 21.2% | 0.01% | |||
3,244,498 | €35.3m | -3.6% | 1.03% | |||
2,759,247 | €30.0m | 2.66% | no data | |||
1,875,313 | €20.4m | 0% | no data | |||
1,728,888 | €18.8m | 8.62% | no data | |||
1,670,733 | €18.2m | 43.9% | 0.03% | |||
1,312,479 | €14.3m | -10.6% | 0.03% | |||
1,299,385 | €14.2m | 2.58% | 0.01% | |||
870,831 | €9.5m | 9.65% | no data | |||
644,970 | €7.0m | 7.78% | 0.27% | |||
479,452 | €5.2m | 0% | 0.86% | |||
462,475 | €5.0m | 2,790% | no data | |||
427,163 | €4.7m | 0% | 0.23% | |||
404,718 | €4.4m | 0% | no data | |||
339,153 | €3.7m | 20% | no data | |||
330,442 | €3.6m | 338% | 0.01% | |||
321,918 | €3.5m | -19.1% | no data | |||
316,134 | €3.4m | 9.29% | no data | |||
265,010 | €2.9m | 38.5% | no data |